Acute Pancreatitis: Etiology, Severity Assessment, and Management

Acute pancreatitis is an inflammatory condition of the pancreas characterized by the inappropriate activation of pancreatic enzymes within the pancreatic parenchyma, leading to autodigestion and inflammation. [KEY_CONCEPT] The diagnosis requires at least 2 of the following 3 criteria: characteristic abdominal pain, serum lipase or amylase ≥3 times the upper limit of normal, or characteristic imaging findings.

Pathophysiology involves the premature activation of pancreatic zymogens (inactive enzyme precursors) within acinar cells rather than in the duodenal lumen. This leads to:

• Trypsinogen activation → trypsin formation within pancreatic cells • Enzymatic autodigestion of pancreatic tissue • Local inflammatory response with cytokine release • Systemic inflammatory response syndrome (SIRS) in severe cases • Microvascular injury leading to increased capillary permeability

[HIGH_YIELD] The severity of acute pancreatitis ranges from mild self-limiting disease to severe necrotizing pancreatitis with multiorgan failure. Mild pancreatitis (85% of cases) lacks organ failure and local/systemic complications. Moderately severe pancreatitis involves transient organ failure (<48 hours) or local complications. Severe pancreatitis features persistent organ failure (>48 hours) and carries significant mortality risk.

[CLINICAL_PEARL] Early recognition and appropriate fluid resuscitation within the first 12-24 hours are crucial for preventing progression to severe disease and reducing mortality.

The etiology of acute pancreatitis follows the mnemonic "GET SMASHED" with gallstones and alcohol accounting for 70-80% of cases.

[HIGH_YIELD] Hypertriglyceridemia-induced pancreatitis typically occurs when triglyceride levels exceed 1000 mg/dL and requires immediate triglyceride reduction through plasmapheresis or insulin therapy.

Risk Factors for Severe Disease: • Age >60 years • Obesity (BMI >30) • Comorbid conditions (diabetes, chronic kidney disease) • Alcohol etiology • Extensive pancreatic necrosis (>30%) • Early organ failure

[CLINICAL_PEARL] Always obtain a detailed medication history, as drug-induced pancreatitis can be easily overlooked and may recur with re-exposure to the offending agent.

Clinical Presentation typically includes the classic triad of severe epigastric pain, nausea/vomiting, and elevated pancreatic enzymes.

Cardinal Symptoms: • Abdominal pain (95% of patients)

• Severe, constant epigastric pain
• Radiates to the back (50% of cases)
• Worsens when supine, improves when leaning forward
• Rapid onset, reaching maximum intensity within hours • Nausea and vomiting (80-90%) • Fever (70-85%) • Abdominal tenderness with guarding

Physical Examination Findings: • Epigastric tenderness with guarding • Decreased bowel sounds (ileus) • Grey Turner sign (flank ecchymosis) - late finding • Cullen sign (periumbilical ecchymosis) - late finding • Jaundice (if biliary obstruction present)

Diagnostic Criteria (Atlanta Classification - Revised 2012):

Diagnosis requires ≥2 of the following:

1. Clinical: ☐ Characteristic abdominal pain ☐ Sudden onset, severe, persistent ☐ Epigastric location ± back radiation

2. Laboratory: ☐ Serum lipase ≥3× upper limit normal, OR ☐ Serum amylase ≥3× upper limit normal

3. Imaging: ☐ Characteristic CT findings ☐ Pancreatic inflammation/necrosis ☐ Peripancreatic fluid collections

[HIGH_YIELD] Lipase is preferred over amylase because it: • Remains elevated longer (7-14 days vs 3-5 days) • Has higher specificity for pancreatic disease • Less affected by renal function • Not elevated in parotitis or bowel perforation

Additional Laboratory Studies: • Complete metabolic panel - assess for organ dysfunction • Liver function tests - evaluate for biliary etiology • Triglycerides - rule out hypertriglyceridemia • Calcium - hypocalcemia indicates severe disease • LDH - marker of tissue necrosis

[CLINICAL_PEARL] Normal pancreatic enzymes do not rule out acute pancreatitis, especially in chronic alcohol users who may have diminished pancreatic reserve.

Severity Assessment is crucial for determining appropriate level of care and predicting outcomes. Multiple scoring systems are available.

APACHE-II Score (most widely validated): • Age, physiologic variables, chronic health • Score ≥8 predicts severe disease • Should be calculated within 24 hours

BISAP Score (Bedside Index of Severity in Acute Pancreatitis):

Score ≥3 = Severe pancreatitis

[HIGH_YIELD] SIRS Criteria (≥2 required): • Temperature >38°C or <36°C • Heart rate >90 bpm • Respiratory rate >20 or PaCO₂ <32 mmHg • WBC >12,000 or <4,000 or >10% bands

Imaging Guidelines:

Imaging Algorithm:

1. Clinical Diagnosis Clear? ├─ Yes → No initial imaging needed └─ No → Proceed to imaging

2. Initial Imaging (if indicated): ├─ CT with IV contrast ├─ Assess for complications └─ Grade severity (CTSI)

3. Follow-up Imaging: ├─ Worsening clinical status ├─ Suspected complications ├─ No improvement after 48-72 hours └─ Evaluate for intervention

4. MRCP/ERCP: ├─ Suspected biliary etiology ├─ Persistent jaundice └─ Failed conservative management

CT Severity Index (CTSI): • Grade A-E based on pancreatic inflammation • Necrosis scoring (0-6 points) • Total score 0-10 correlates with morbidity/mortality

Indications for Early Imaging: • Diagnostic uncertainty • Clinical deterioration • BISAP score ≥3 • Persistent organ failure • Suspected complications

[CLINICAL_PEARL] Avoid IV contrast in patients with acute kidney injury or severe dehydration. CECT should be delayed 48-72 hours after symptom onset to allow full development of pancreatic necrosis.

Management of acute pancreatitis focuses on supportive care, early aggressive fluid resuscitation, and treatment of underlying causes.

Initial Management (First 24 Hours):

Immediate Assessment & Stabilization:

1. Severity Assessment ├─ BISAP or APACHE-II scoring ├─ Identify organ failure └─ ICU vs floor admission

2. Fluid Resuscitation ├─ Lactated Ringer's preferred ├─ 15-20 mL/kg bolus initially ├─ Then 250-500 mL/hr maintenance └─ Goal: UOP >0.5-1 mL/kg/hr

3. Pain Management ├─ IV opioids (morphine, fentanyl) ├─ Avoid meperidine └─ PCA pump if needed

4. Nutrition Assessment ├─ NPO initially if severe nausea ├─ Early oral feeding if tolerated └─ Enteral nutrition within 48-72 hours

[HIGH_YIELD] Fluid Resuscitation Principles: • Lactated Ringer's solution is preferred over normal saline • Goal-directed therapy targeting:

• Heart rate <120 bpm
• Mean arterial pressure 65-85 mmHg
• Urine output >0.5 mL/kg/hr
• Hematocrit 35-44%

Nutritional Management: • Early oral feeding (within 24-48 hours) if tolerated • Start with clear liquids, advance as tolerated • Enteral nutrition preferred over parenteral • Nasojejunal feeding if unable to tolerate oral intake • Avoid pancreatic rest - not beneficial

Specific Treatments by Etiology:

Monitoring Parameters: • Vital signs every 4 hours • Daily comprehensive metabolic panel • Fluid balance (I/Os) • Pain scores • Clinical improvement markers

Medications to Avoid: • Antibiotics (unless infected necrosis) • Proton pump inhibitors (unless active GI bleeding) • Octreotide or other somatostatin analogs • Pancreatic enzyme replacement (acute phase)

[CLINICAL_PEARL] Early aggressive fluid resuscitation within the first 12-24 hours is the most important intervention to prevent severe pancreatitis and reduce mortality.

Complications of acute pancreatitis can be local (pancreatic/peripancreatic) or systemic and may develop early (<4 weeks) or late (>4 weeks).

Local Complications:

Systemic Complications: • Acute kidney injury (25-35% of severe cases) • Acute respiratory distress syndrome (ARDS) • Cardiovascular collapse/shock • Gastrointestinal bleeding • Hyperglycemia/diabetes mellitus • Hypocalcemia (fat saponification) • Disseminated intravascular coagulation

[HIGH_YIELD] Infected Pancreatic Necrosis: • Occurs in 20-30% of necrotizing pancreatitis • Suspect if: fever, leukocytosis, clinical deterioration >7-10 days • Diagnosis: CT-guided FNA with Gram stain and culture • Treatment: Antibiotics + delayed intervention (4-6 weeks if possible) • Step-up approach: percutaneous drainage → endoscopic debridement → surgical necrosectomy

Prognosis Factors:

Mortality Risk: • Mild pancreatitis: <1% • Moderately severe: 1-3% • Severe pancreatitis: 10-25% • Infected necrosis: 15-40%

Poor Prognostic Indicators: • Age >60 years • Organ failure within 24 hours • Obesity (BMI >30) • Extensive necrosis (>30%) • Infected necrosis • Multiple comorbidities

Long-term Sequelae: • Exocrine insufficiency (10-15% after severe pancreatitis) • Endocrine insufficiency (diabetes mellitus in 15-20%) • Chronic pancreatitis (rare after single episode) • Recurrent pancreatitis if underlying cause not addressed

[CLINICAL_PEARL] The "golden 24 hours" concept emphasizes that aggressive supportive care in the first day significantly impacts outcomes. Most deaths in severe pancreatitis occur from early multiorgan failure rather than late infectious complications.

Follow-up Recommendations: • Gallstone pancreatitis: Cholecystectomy during same admission or within 2 weeks • Alcohol-related: Substance abuse counseling and monitoring • Idiopathic: Genetic testing if recurrent or family history • All patients: Diabetes screening, exocrine function assessment if indicated